The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...
Chronic rhinosinusitis with nasal polyps is treated with nasally administered corticosteroids and, as the diseases progresses, also with orally administered corticosteroids. If these treatments ...
News Medical on MSN5d
Asthma and antibiotic use increase the likelihood of revision sinus surgeryThe probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...
Nasal polyps are benign mucosal protrusions that ... Chronic polypotic rhinosinusitis is treated with nasally administered corticosteroids and, as the diseases progresses, also with orally ...
GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...
HealthDay on MSN3d
Baseline Characteristics ID Risk for Recurrent Endoscopic Sinus SurgeryTHURSDAY, Feb. 6, 2025 (HealthDay News) -- A few baseline characteristics can predict the need for recurrent endoscopic sinus ...
EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback